Skip to main content
OpenTrials

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

885 public trials 210 recruiting studies
Refine in advanced search Browse all conditions

TDP-43 Proteinopathies trial results

Recruiting

Tofersen in Non-SOD1 ALS

NCT07294144

Conditions
ALS (Amyotrophic Lateral Sclerosis), Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +9 more
Locations
  • Emory University Atlanta, Georgia, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University ALS Center St Louis, Missouri, United States
View Trial Details
Recruiting

Clinical Procedures to Support Research in ALS

NCT03489278

Conditions
ALS-Frontotemporal Dementia, Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +12 more
Locations
  • University of California, Irvine Irvine, California, United States
  • Stanford University Palo Alto, California, United States
  • California Pacific Medical Center San Francisco, California, United States
  • University of Miami Miami, Florida, United States
View Trial Details
Recruiting

A Study of Ranolazine in ALS

NCT06527222

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • University of Kansas Medical Center Fairway, Kansas, United States
  • University of Kansas Medical Center: Wichita Wichita, Kansas, United States
View Trial Details

Related conditions